Universal Corporation Reports First Half and Second Quarter 2026 Results

November 5, 2025

Revenue up 3% and 6% for First Half and Second Quarter 2026, respectively

Operating Income up 18% for First Half and down 2% for Second Quarter 2026

Continued Strong Operational Performance in First Half of Fiscal Year 2026

Universal Corporation (NYSE:UVV) (“Universal” or the “Company”), a global business-to-business agriproducts company, today announced financial results for the six months and quarter ended September 30, 2025.

Preston D. Wigner, Chairman, President, and Chief Executive Officer of Universal, stated, “We are proud of the strong operational performance of both of our business segments in the first half of fiscal year 2026. Our Tobacco Operations segment achieved solid results. Customer demand has remained firm following several years of undersupply, despite significantly larger tobacco crops this fiscal year. Tobacco buying has been completed in most key growing regions, and green tobacco prices have softened in certain regions compared to the previous fiscal year. Shipments are progressing smoothly, and current crop tobacco is being shipped earlier than in the prior fiscal year. Overall, the segment has once again demonstrated effective management in navigating market dynamics."

Mr. Wigner continued, “Our Ingredients Operations segment maintained positive momentum, achieving higher sales and volume in both the quarter and six months ended September 30, 2025. Continued interest in new value-added products has translated into an active pipeline, supported by Universal Ingredients' enhanced production and operational capabilities. Demand for our new products remains solid, while fixed costs, product mix, and market challenges, including weakness in the consumer-packaged goods industry and tariff uncertainty, had a negative impact on earnings. The segment’s proactive approach to meeting customers’ strategic needs, focusing on organic growth, and converting customer interest into sales will continue to build scale and generate returns on our investments. We believe the segment continues to be well-positioned to capitalize on its investments and drive future growth."

FINANCIAL HIGHLIGHTS

Three Months Ended September 30,

Change

Six Months Ended September 30,

Change

(in millions of dollars, except per share data)

2025

2024

%

2025

2024

%

Consolidated Results

Sales and other operating revenue

$

754.2

$

710.8

6

%

$

1,347.9

$

1,307.8

3

%

Cost of goods sold

$

614.3

$

567.6

8

%

$

1,094.0

$

1,068.7

2

%

Gross profit margin percentage

18.5

%

20.1

%

-160 bps

18.8

%

18.3

%

50 bps

Selling, general and administrative expenses

$

72.2

$

63.8

13

%

$

151.4

$

142.5

6

%

Restructuring and impairment costs

$

$

10.6

(100

)%

$

1.1

$

10.6

(89

)%

Operating income

$

67.6

$

68.7

(2

)%

$

101.5

$

86.0

18

%

Adjusted operating income (non-GAAP)*

$

67.6

$

79.3

(15

)%

$

102.6

$

96.5

6

%

Net income attributable to Universal Corporation

$

34.2

$

25.9

32

%

$

42.7

$

26.1

64

%

Adjusted net income attributable to Universal Corporation (non-GAAP)*

$

34.2

$

36.4

(6

)%

$

43.8

$

36.5

20

%

Diluted earnings (loss) per share

$

1.36

$

1.03

32

%

$

1.70

$

1.04

63

%

Adjusted diluted earnings (loss) per share (non-GAAP)*

$

1.36

$

1.45

(6

)%

$

1.74

$

1.46

19

%

Segment Results

Tobacco operations sales and other operating revenues

$

659.4

$

630.2

5

%

$

1,164.1

$

1,142.2

2

%

Tobacco operations operating income

$

65.2

$

77.3

(16

)%

$

100.9

$

91.8

10

%

Ingredients operations sales and other operating revenues

$

94.8

$

80.6

18

%

$

183.8

$

165.6

11

%

Ingredients operations operating income (loss)

$

(0.2

)

$

1.3

(112

)%

$

1.5

$

4.2

(64

)%

*

See Reconciliation of Certain non-GAAP Financial Measures in Other Items below

First Half 2026 Highlights

Consolidated Results

  • Revenue up $40 million to $1.3 billion on higher third-party tobacco processing volumes, accelerated tobacco shipments, and higher ingredients sales volumes.
  • Operating income up $16 million to $102 million on a favorable product mix in the Tobacco Operations segment.

Tobacco Operations Segment

  • Revenue up $22 million on higher third-party tobacco processing volumes.
  • Segment operating income up $9 million on a favorable product mix.
  • Tobacco sales volumes slightly down, about 1%, as higher sales and earlier shipments of current crop tobacco largely offset lower sales of carryover crop tobacco.
  • Tobacco sales prices relatively flat.
  • Tobacco Operations segment results reflected:
    • Continued firm customer demand;
    • A favorable product mix;
    • Larger current crops, particularly in Brazil and African origins;
    • Earlier shipments of current crop tobacco;
    • Lower sales of carryover crop tobacco;
    • Increased third-party tobacco processing revenue; and
    • Higher inventory write-downs.
  • Uncommitted tobacco inventory levels have remained low at approximately 13% at September 30, 2025.
  • Currently tobacco supply and demand is generally in a balanced position but is expected to move to an oversupply position by fiscal year-end.

Ingredients Operations Segment

  • Revenue up 11% on increased sales volumes.
  • Lower operating income reflected product mix and higher fixed costs, including additional depreciation from our recently expanded production facility, as well as inventory write-downs. Weakness in the consumer-packaged goods industry and tariff uncertainty also impacted the segment.
  • Despite market challenges, continued high level of interest in value-added products.
  • Ongoing focus on organic growth and building scale through our product pipeline.

Select Balance Sheet Items, Liquidity, and Debt

  • Increased working capital usage on seasonal tobacco purchases.
  • Total debt down $39 million at September 30, 2025, compared to September 30, 2024.
  • Net debt (non-GAAP) down $52 million at September 30, 2025, compared to September 30, 2024.
  • Approximately $340 million available under revolving credit facility as of September 30, 2025.

Additional Items

  • Restructuring and impairment costs of $1.1 million in the first half of fiscal year 2026, compared to $10.6 million in the first half of fiscal year 2025.
  • Interest expense down $4 million, compared to the same period in the prior fiscal year.

Second Quarter 2026 Highlights

Consolidated Results

  • Revenue up $43 million, to $754 million, on higher tobacco and ingredient sales volumes.
  • Operating income down $1 million to $68 million on higher sales volumes and lower restructuring and impairment costs, slightly offset by unfavorable foreign currency comparisons, higher inventory write-downs, and higher provisions for farmer advances.

Tobacco Operations Segment

  • Revenue up $29 million, or 5%, on higher tobacco sales volumes.
  • Segment operating income down $12 million on unfavorable foreign currency comparisons, higher inventory write-downs, and a less favorable product mix.

Ingredients Operations Segment

  • Revenue up 18% on increased sales volumes.
  • Lower operating income reflected product mix and higher fixed costs, including additional depreciation from our recently expanded production facility, as well as inventory write-downs. Weakness in the consumer-packaged goods industry and tariff uncertainty also impacted the segment.

Additional Items

  • Restructuring and impairment costs of $10.6 million in the quarter ended September 30, 2024.

Sustainability Update

Universal Corporation continues to make meaningful progress in its transition to renewable and lower emission energy sources. The Company has significantly expanded its use of clean electricity as an important element of its carbon transition plan.

“Our continued progress in expanding renewable electricity use demonstrates Universal’s commitment to operational efficiency and environmental stewardship,” said Mr. Wigner. “Investing in clean energy supports our sustainability goals and strengthens the resilience of our operations while creating long-term value for our stakeholders.”

Expanded solar capacity has played a central role in this progress. On-site solar installations in Italy, the Dominican Republic, and the Philippines have further strengthened Universal’s clean energy footprint.

Other Items

Reconciliation of Certain Non-GAAP Financial Measures

Adjusted operating income (loss), adjusted net income (loss) attributable to Universal Corporation, adjusted diluted earnings (loss) per share, and the total for segment operating income (loss) are non-GAAP financial measures. These measures are not financial measures calculated in accordance with generally accepted accounting principles ("GAAP") and should not be considered as substitutes for operating income (loss), net income (loss) attributable to Universal Corporation, diluted earnings (loss) per share, cash from operating activities or any other operating or financial performance measure calculated in accordance with GAAP, and may not be comparable to similarly-titled measures reported by other companies. Reconciliations of adjusted operating income (loss) to consolidated operating (income), adjusted net income (loss) attributable to Universal Corporation to consolidated net income (loss) attributable to Universal Corporation and adjusted diluted earnings (loss) per share to diluted earnings (loss) per share are provided below. In addition, a reconciliation of the total for segment operating income (loss) to consolidated operating income (loss) is provided in Note 3. "Segment Information" to the consolidated financial statements. Management evaluates the consolidated Company and segment performance excluding certain significant charges or credits. Management believes these non-GAAP financial measures, which exclude items that it believes are not indicative of its core operating results, can provide investors with important information that is useful in understanding its business results and trends.

Net debt, net capitalization, and net debt to net capitalization ratio are also non-GAAP financial measures. These measures are not financial measures calculated in accordance with GAAP and should not be considered substitutes for total debt, total capitalization, total debt to total capitalization ratio, or any other operating or financial performance measures calculated in accordance with GAAP, and may not be comparable to similarly-titled measures reported by other companies. Reconciliations of net debt to total debt and net capitalization to total capitalization are provided below. Management believes these non-GAAP measures are meaningful indicators of liquidity and financial position.

The following tables set forth certain non-recurring items included in reported results to reconcile adjusted operating income to consolidated operating income and adjusted net income to net income attributable to Universal Corporation:

Adjusted Operating Income Reconciliation

Three Months Ended September 30,

Six Months Ended September 30,

(in thousands)

2025

2024

2025

2024

As Reported: Consolidated operating income

$

67,649

$

68,736

$

101,462

$

85,961

Restructuring and impairment costs(1)

10,573

1,122

10,573

As Adjusted operating income (non-GAAP)

$

67,649

$

79,309

$

102,584

$

96,534

Adjusted Net Income Attributable to Universal Corporation and Adjusted Diluted Earnings Per Share Reconciliation

(in thousands except for per share amounts)

Three Months Ended September 30,

Six Months Ended September 30,

2025

2024

2025

2024

As Reported: Net income attributable to Universal Corporation

$

34,169

$

25,940

$

42,666

$

26,070

Restructuring and impairment costs(1)

10,573

1,122

10,573

Total of non-GAAP adjustments to income before income taxes

10,573

1,122

10,573

Non-GAAP adjustments to income taxes

Income tax benefit from restructuring and impairment costs(2)

(132

)

(35

)

(132

)

Total of income tax impacts for non-GAAP adjustments to income before income taxes

(132

)

(35

)

(132

)

As adjusted: Net income attributable to Universal Corporation (non-GAAP)

$

34,169

$

36,381

$

43,753

$

36,511

As reported: Diluted earnings per share

$

1.36

$

1.03

$

1.70

$

1.04

As adjusted: Diluted earnings per share (non-GAAP)

$

1.36

$

1.45

$

1.74

$

1.46

(1)

Restructuring and impairment costs are included in Consolidated operating income in the consolidated statements of income, but excluded for purposes of Adjusted operating income, Adjusted net income available to Universal Corporation, and Adjusted diluted earnings per share.

(2)

The income tax effect of non-GAAP adjustments was determined based on the timing and nature of the specific non-GAAP adjustments and their relevant jurisdictional income tax rates (foreign, state, and local) and the applicable U.S. federal income tax rates. The Company considers current and deferred income tax rates to calculate the impact to income taxes for the non-GAAP adjustments.

The following table reconciles total debt to net debt and net capitalization:

Net Debt and Net Capitalization Reconciliation

September 30,

September 30,

March 31,

(in thousands)

2025

2024

2025

Add: Notes payable and overdrafts

$

539,583

$

579,132

$

455,039

Add: Long-term obligations

618,196

617,641

617,918

Add: Current portion of long-term obligations

Total Debt

1,157,779

1,196,773

1,072,957

Add: Customer advances and deposits

2,782

6,837

3,763

Less: Cash and cash equivalents

88,652

80,118

260,115

Net Debt (non-GAAP)

$

1,071,909

$

1,123,492

$

816,605

Add: Total Universal Corporation shareholders' equity

1,469,982

1,420,566

1,458,556

Net Capitalization (non-GAAP)

$

2,541,891

$

2,544,058

$

2,275,161

Net Debt/Net Capitalization (non-GAAP)

42

%

44

%

36

%

Investor Conference Call

At 10:00 a.m. (Eastern Time) on November 6, 2025, the Company will host a conference call to discuss these results. Those wishing to listen to the call may do so by visiting www.universalcorp.com at that time. A replay of the webcast will be available at that site through February 6, 2026. A taped replay of the call will also be available through November 20, 2025, by dialing (800) 770-2030 (Playback ID: 5786366#).

About Universal Corporation

Universal Corporation (NYSE: UVV) is a global agricultural company with over 100 years of experience supplying products and innovative solutions to meet our customers’ evolving needs and precise specifications. Through our diverse network of farmers and partners across more than 30 countries on five continents, we are a trusted provider of high-quality, traceable products. We leverage our extensive supply chain expertise, global reach, integrated processing capabilities, and commitment to sustainability to provide a range of products and services designed to drive efficiency and deliver value to our customers. For more information, visit www.universalcorp.com.

CAUTIONARY STATEMENTS REGARDING FORWARD-LOOKING INFORMATION

This release includes “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Among other things, these statements include statements made in Mr. Wigner’s quotations, statements regarding expectations with respect to our fiscal year 2026 performance, our strategic plans, ingredients business, tobacco business, including expectations with respect to size, shipments and sales and purchases of tobacco crops. These forward-looking statements are generally identified by the use of words such as we “expect,” “believe,” “anticipate,” “could,” “should,” “may,” “plan,” “will,” “predict,” “estimate,” and similar expressions or words of similar import. These forward-looking statements are based upon management’s current knowledge and assumptions about future events and involve risks and uncertainties that could cause actual results, performance, or achievements to be materially different from any anticipated results, prospects, performance, or achievements expressed or implied by such forward-looking statements. Such risks and uncertainties include, but are not limited to: product purchased not meeting quality and quantity requirements; reliance on a few large customers; anticipated levels of demand for and supply of our products and services; tobacco growing conditions and customer requirements; major shifts in customer requirements for leaf tobacco; higher inflation rates, tariffs and other pressures on costs; weather and other conditions; exposure to certain legal, regulatory and financial risks related to climate change; industry-specific risks related to our plant-based ingredients businesses; disruption of our supply chain for our plant-based ingredients; success in pursuing strategic investments or acquisitions and integration of new businesses and the impact of these new businesses on future results; our ability to maintain effective information technology systems and safeguard confidential information; our inability to attract, develop, retain, motivate, and maintain good relationships with our workforce; our dependence on a seasonal workforce; epidemics, pandemics or similar widespread public health concerns; government efforts to regulate the production and consumption of tobacco products; government actions on the sourcing of leaf tobacco; economic and political conditions in the countries in which we and our customers operate, including the ongoing impacts from international conflicts; sustainability considerations from governments and other stakeholders; changes in tax laws in the countries where we do business; material weaknesses in our internal control over financial reporting; our inability to use a Form S-3 registration statement; failure of our customers or suppliers to repay extensions of credit; changes in exchange rates; changes in interest rates; and low investment performance by our defined benefit pension plan assets and changes in pension plan valuation assumptions. Please also refer to the risks and uncertainties as discussed in Part I, Item 1A. “Risk Factors” of Universal’s Annual Report on Form 10-K for the fiscal year ended March 31, 2025, and related disclosures in other filings that Universal files with the Securities and Exchange Commission (the "SEC") which are available on the SEC’s website at www.sec.gov. All risk factors and uncertainties described herein and therein should be considered in evaluating forward-looking statements, and all of the forward-looking statements are expressly qualified by the cautionary statements contained or referred to herein and therein. Universal cautions investors not to place undue reliance on any forward-looking statements as these statements speak only as of the date when made, and it undertakes no obligation to update any forward-looking statements made, except as required by law.

UNIVERSAL CORPORATION

CONSOLIDATED STATEMENTS OF INCOME

(in thousands of dollars, except per share data)

Three Months Ended September 30,

Six Months Ended September 30,

2025

2024

2025

2024

(Unaudited)

(Unaudited)

Sales and other operating revenues

$

754,177

$

710,762

$

1,347,939

$

1,307,812

Costs and expenses

Cost of goods sold

614,347

567,617

1,093,982

1,068,746

Selling, general and administrative expenses

72,181

63,836

151,373

142,532

Restructuring and impairment costs

10,573

1,122

10,573

Operating income

67,649

68,736

101,462

85,961

Equity in pretax earnings (loss) of unconsolidated affiliates

(2,561

)

(642

)

(126

)

(502

)

Other non-operating income (expense)

582

461

1,168

925

Interest income

778

295

1,425

1,103

Interest expense

20,438

21,273

38,215

42,007

Income (loss) before income taxes and other items

46,010

47,577

65,714

45,480

Income taxes

11,207

13,608

16,544

14,335

Net income (loss)

34,803

33,969

49,170

31,145

Less: net loss (income) attributable to noncontrolling interests in subsidiaries

(634

)

(8,029

)

(6,504

)

(5,075

)

Net income (loss) attributable to Universal Corporation

$

34,169

$

25,940

$

42,666

$

26,070

Earnings per share:

Basic

$

1.36

$

1.04

$

1.71

$

1.05

Diluted

$

1.36

$

1.03

$

1.70

$

1.04

See accompanying notes.

UNIVERSAL CORPORATION

CONSOLIDATED BALANCE SHEETS

(in thousands of dollars)

September 30,

September 30,

March 31,

2025

2024

2025

(Unaudited)

(Unaudited)

ASSETS

Current assets

Cash and cash equivalents

$

88,652

$

80,118

$

260,115

Accounts receivable, net

445,257

537,602

625,876

Advances to suppliers, net

121,569

139,766

169,385

Accounts receivable—unconsolidated affiliates

114,071

66,646

7,143

Inventories—at lower of cost or net realizable value:

Tobacco

1,138,630

1,070,655

806,332

Other

222,505

211,476

189,610

Prepaid income taxes

23,066

20,771

19,595

Other current assets

85,928

84,884

78,041

Total current assets

2,239,678

2,211,918

2,156,097

Property, plant and equipment

Land

26,285

25,972

26,113

Buildings

335,300

330,407

333,398

Machinery and equipment

746,284

705,246

723,935

1,107,869

1,061,625

1,083,446

Less accumulated depreciation

(735,473

)

(685,883

)

(710,472

)

372,396

375,742

372,974

Other assets

Operating lease right-of-use assets

37,319

32,487

34,260

Goodwill, net

213,815

213,872

213,840

Other intangibles, net

52,650

63,263

57,836

Investments in unconsolidated affiliates

84,526

78,774

79,317

Deferred income taxes

18,238

15,526

16,539

Pension asset

13,393

12,293

12,819

Other noncurrent assets

38,424

41,711

45,870

458,365

457,926

460,481

Total assets

$

3,070,439

$

3,045,586

$

2,989,552

See accompanying notes.

UNIVERSAL CORPORATION

CONSOLIDATED BALANCE SHEETS

(in thousands of dollars)

September 30,

September 30,

March 31,

2025

2024

2025

(Unaudited)

(Unaudited)

LIABILITIES AND SHAREHOLDERS’ EQUITY

Current liabilities

Notes payable and overdrafts

$

539,583

$

579,132

$

455,039

Accounts payable

99,599

87,106

98,036

Accounts payable—unconsolidated affiliates

299

174

1,999

Customer advances and deposits

2,782

6,837

3,763

Accrued compensation

30,776

29,266

44,646

Income taxes payable

14,573

7,948

12,586

Current portion of operating lease liabilities

11,809

10,325

10,742

Accrued expenses and other current liabilities

129,210

128,634

123,350

Current portion of long-term debt

Total current liabilities

828,631

849,422

750,161

Long-term debt

618,196

617,641

617,918

Pensions and other postretirement benefits

36,490

36,734

35,336

Long-term operating lease liabilities

23,584

19,038

20,608

Other long-term liabilities

26,228

28,425

22,901

Deferred income taxes

33,160

36,322

42,090

Total liabilities

1,566,289

1,587,582

1,489,014

Shareholders’ equity

Universal Corporation:

Preferred stock:

Series A Junior Participating Preferred Stock, no par value, 500,000 shares authorized, none issued or outstanding

Common stock, no par value, 100,000,000 shares authorized 24,913,747 shares issued and outstanding at September 30, 2025 (24,715,625 at September 30, 2024 and 24,715,625 at March 31, 2025)

352,909

349,064

351,626

Retained earnings

1,188,283

1,158,658

1,186,981

Accumulated other comprehensive loss

(71,210

)

(87,156

)

(80,051

)

Total Universal Corporation shareholders' equity

1,469,982

1,420,566

1,458,556

Noncontrolling interests in subsidiaries

34,168

37,438

41,982

Total shareholders' equity

1,504,150

1,458,004

1,500,538

Total liabilities and shareholders' equity

$

3,070,439

$

3,045,586

$

2,989,552

See accompanying notes.

UNIVERSAL CORPORATION

CONSOLIDATED STATEMENTS OF CASH FLOWS

(in thousands of dollars)

Six Months Ended September 30,

2025

2024

(Unaudited)

CASH FLOWS FROM OPERATING ACTIVITIES:

Net income (loss)

$

49,170

$

31,145

Adjustments to reconcile net income (loss) to net cash used by operating activities:

Depreciation and amortization

27,198

29,420

Net provision for losses (recoveries) on advances to suppliers

(2,810

)

(5,562

)

Inventory writedowns

9,780

5,231

Stock-based compensation expense

8,481

6,583

Foreign currency remeasurement (gain) loss, net

1,195

1,334

Foreign currency exchange contracts

(2,531

)

3,225

Deferred income taxes

(9,726

)

153

Equity in net loss (income) of unconsolidated affiliates, net of dividends

991

404

Restructuring and impairment costs

1,122

10,573

Restructuring payments

(2,774

)

(350

)

Other, net

37

(217

)

Changes in operating assets and liabilities, net:

(252,491

)

(129,352

)

Net cash used by operating activities

(172,358

)

(47,413

)

CASH FLOWS FROM INVESTING ACTIVITIES:

Purchase of property, plant and equipment

(21,099

)

(38,796

)

Proceeds from sale of property, plant and equipment

881

1,412

Net cash used by investing activities

(20,218

)

(37,384

)

CASH FLOWS FROM FINANCING ACTIVITIES:

Issuance of short-term debt, net

82,781

161,611

Dividends paid to noncontrolling interests

(14,063

)

(8,960

)

Dividends paid on common stock

(40,426

)

(39,646

)

Other

(7,727

)

(3,716

)

Net cash provided by financing activities

20,565

109,289

Effect of exchange rate changes on cash, restricted cash and cash equivalents

548

33

Net increase (decrease) in cash, restricted cash and cash equivalents

(171,463

)

24,525

Cash, restricted cash and cash equivalents at beginning of year

260,115

55,593

Cash, restricted cash and cash equivalents at end of period

$

88,652

$

80,118

See accompanying notes.

NOTE 1. BASIS OF PRESENTATION

Universal Corporation, which together with its subsidiaries is referred to herein as “Universal” or the “Company,” is a global business-to-business agri-products supplier to consumer product manufacturers. The Company is the leading global leaf tobacco supplier and provides high-quality plant-based ingredients to food and beverage end markets. Because of the seasonal nature of the Company’s business, the results of operations for any fiscal quarter will not necessarily be indicative of results to be expected for other quarters or a full fiscal year. All adjustments necessary to state fairly the results for the period have been included and were of a normal recurring nature. These financial statements should be read in conjunction with the financial statements and notes thereto included in the Company’s Annual Report on Form 10-K for the fiscal year ended March 31, 2025.

NOTE 2. EARNINGS PER SHARE

The following table sets forth the computation of basic and diluted earnings per share:

Three Months Ended
September 30,

Six Months Ended
September 30,

(in thousands, except share and per share data)

2025

2024

2025

2024

Basic Earnings (Loss) Per Share

Numerator for basic earnings (loss) per share

Net income (loss) attributable to Universal Corporation

$

34,169

$

25,940

$

42,666

$

26,070

Denominator for basic earnings (loss) per share

Weighted average shares outstanding

25,035,110

24,946,632

25,017,765

24,911,681

Basic earnings (loss) per share

$

1.36

$

1.04

$

1.71

$

1.05

Diluted Earnings (Loss) Per Share

Numerator for diluted earnings (loss) per share

Net income (loss) attributable to Universal Corporation

$

34,169

$

25,940

$

42,666

$

26,070

Denominator for diluted earnings (loss) per share:

Weighted average shares outstanding

25,035,110

24,946,632

25,017,765

24,911,681

Effect of dilutive securities

Employee and outside director share-based awards

143,436

189,341

137,862

189,614

Denominator for diluted earnings (loss) per share

25,178,546

25,135,973

25,155,627

25,101,295

Diluted earnings (loss) per share

$

1.36

$

1.03

$

1.70

$

1.04

NOTE 3. SEGMENT INFORMATION

Management regularly evaluates the Company’s global business activities, including product and service offerings to its customers, as well as senior management’s operational and financial responsibilities. Assessments include an analysis of how its Chief Operating Decision Maker (“CODM”) measures business performance and allocates resources. As a result of this analysis, senior management has determined the Company conducts operations across two reportable operating segments, Tobacco Operations and Ingredients Operations.

The Tobacco Operations segment activities involve contracting, procuring, processing, packing, storing, and shipping leaf tobacco for sale to, or for the account of, manufacturers of consumer tobacco products throughout the world. Through various operating subsidiaries located in tobacco-growing countries around the world and significant ownership interests in unconsolidated affiliates, the Company processes and/or sells flue-cured and burley tobaccos, dark air-cured tobaccos, and oriental tobaccos. Flue-cured, burley, and oriental tobaccos are used principally in the manufacture of cigarettes, and dark air-cured tobaccos are used mainly in the manufacture of cigars, pipe tobacco, and smokeless tobacco products. Some of these tobacco types are also used in the manufacture of next generation tobacco products that are intended to provide consumers with an alternative to traditional combustible products. The Tobacco Operations segment also provides physical and chemical product testing for tobacco customers. A substantial portion of the Company’s Tobacco Operations’ revenues are derived from sales to a limited number of large, multinational cigarette and cigar manufacturers.

The Ingredients Operations segment provides its customers with a broad variety of plant-based ingredients for both human and pet consumption. The Ingredients Operations segment utilizes a variety of value-added manufacturing processes converting raw materials into a wide spectrum of fruit and vegetable juices, concentrates, dehydrated products, botanical extracts, and flavorings. Customers for the Ingredients Operations segment include large multinational food and beverage companies, smaller independent manufacturers, and retail organizations. FruitSmart, Inc. (“FruitSmart”), Silva International, Inc. (“Silva”), and Shank’s Extracts, LLC d/b/a Universal Ingredients–Shank’s (“Universal Ingredients–Shank’s”) are the primary operations for the Ingredients Operations segment. FruitSmart supplies a broad set of juices, concentrates, pomaces, purees, fruit fibers, seeds, seed powders, and other value-added products to food, beverage, and flavor companies throughout the United States and internationally. Silva procures dehydrated vegetables, fruits, and herbs from around the world and specializes in processing natural materials into custom designed dehydrated vegetable and fruit-based ingredients for a variety of end products. Universal Ingredients–Shank’s offers a diversified portfolio of botanical extracts, distillates, natural flavors, and color for industrial and private label customers worldwide, and is known for their significant vanilla expertise. Universal Ingredients–Shank’s is also equipped to offer customers custom bottling and packaging for their products.

Universal incurs corporate overhead expenses related to senior management, sales, finance, legal, and other functions that are centralized at its corporate headquarters, as well as functions performed at several sales and administrative offices around the world. These overhead expenses are currently allocated to the reportable operating segments, generally on the basis of projected annual financial and operational performance, including volumes planned to be purchased and/or processed. Management believes this method of allocation is currently representative of the value of the related services provided to the operating segments. The CODM, which has been identified as a group comprised of the Company’s Chief Executive Officer, Chief Operating Officer, and Chief Financial Officer, currently evaluates the performance of the operating segments based on operating income after allocated overhead expenses, plus equity in the pretax earnings of unconsolidated affiliates (“Segment Operating Income”). The CODM also uses Segment Operating Income for planning, forecasting, and allocating capital and other resources to the operating segments.

Reportable segment data as of, or for, each period presented in the consolidated statements of income and comprehensive income, the consolidated balance sheets, and the consolidated statements of cash flows is as follows:

Three Months Ended September 30, 2025

Three Months Ended September 30, 2024

Tobacco
Operations

Ingredients
Operations

Consolidated

Tobacco
Operations

Ingredients
Operations

Consolidated

Sales and other operating revenues

$

659,423

$

94,754

$

754,177

$

630,212

$

80,550

$

710,762

Cost of goods sold

(534,668

)

(79,679

)

(614,347

)

(503,147

)

(64,470

)

(567,617

)

Selling, general and administrative expenses

(40,057

)

(12,041

)

(52,098

)

(33,657

)

(11,873

)

(45,530

)

Corporate overhead allocated to the segments

(16,889

)

(3,194

)

(20,083

)

(15,432

)

(2,874

)

(18,306

)

Equity in pretax earnings (loss) of unconsolidated affiliates(1)

(2,561

)

(2,561

)

(642

)

(642

)

Segment operating income

65,248

(160

)

65,088

77,334

1,333

78,667

Deduct: Equity in pretax (earnings) loss of unconsolidated affiliates(1)

2,561

642

Restructuring and impairment costs(2)

(10,573

)

Consolidated total

$

67,649

$

68,736

Six Months Ended September 30, 2025

Six Months Ended September 30, 2024

Tobacco
Operations

Ingredients
Operations

Consolidated

Tobacco
Operations

Ingredients
Operations

Consolidated

Sales and other operating revenues

$

1,164,119

$

183,820

$

1,347,939

$

1,142,167

$

165,645

$

1,307,812

Cost of goods sold

(942,535

)

(151,447

)

(1,093,982

)

(937,912

)

(130,834

)

(1,068,746

)

Selling, general and administrative expenses

(84,811

)

(24,078

)

(108,889

)

(80,205

)

(24,652

)

(104,857

)

Corporate overhead allocated to the segments

(35,729

)

(6,755

)

(42,484

)

(31,760

)

(5,915

)

(37,675

)

Equity in pretax earnings (loss) of unconsolidated affiliates(1)

(126

)

(126

)

(502

)

(502

)

Segment operating income

100,918

1,540

102,458

91,788

4,244

96,032

Deduct: Equity in pretax (earnings) loss of unconsolidated affiliates(1)

126

502

Restructuring and impairment costs(2)

(1,122

)

(10,573

)

Consolidated operating income

$

101,462

$

85,961

(1)

Equity in pretax earnings (loss) of unconsolidated affiliates is included in segment operating income (Tobacco Operations), but is reported below consolidated operating income and excluded from that total in the consolidated statements of income and comprehensive income.

(2)

Restructuring and impairment costs are excluded from segment operating income, but are included in consolidated operating income in the consolidated statements of income and comprehensive income.

Universal Corporation Investor Relations
Phone: (804) 359-9311
Fax: (804) 254-3584
Email: investor@universalleaf.com

Source: Universal Corporation